FULC

$3.67-0.54%website ↗⬇ financials (.py)

Fulcrum Therapeutics, Inc.

Market Cap

$245M

Live price × shares (2026-09-17)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

2.59

60mo monthly vs SPY

P/E (TTM)

N/M

Price / TTM net income

P/S (TTM)

—

Price / TTM revenue

P/B

0.8

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

purchases / sales, 90d

Short Volume

61%

W/W +23.7pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →

Velocity Score

23.98x

Avg Daily Buying (90d)

4,640 sh/day

Baseline Daily Buying

0.0 sh/day

Unique Buyers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-07-17	2026-07-20	TANG KEVIN	10% Owner	Purchase	50.9K	$3.52	$179K	7.08M	View
2026-07-16	2026-07-20	TANG KEVIN	10% Owner	Purchase	116.7K	$3.56	$415K	7.03M	View
2026-07-15	2026-07-15	TANG KEVIN	10% Owner	Purchase	107.4K	$3.56	$382K	6.91M	View
2026-07-14	2026-07-15	TANG KEVIN	10% Owner	Purchase	129.6K	$3.57	$463K	6.81M	View
2026-07-13	2026-07-15	TANG KEVIN	10% Owner	Purchase	13.0K	$3.54	$46K	6.68M	View

1–5 of 6

1 / 2

FULC

Signals

Factor Profile

Reporting Insiders

Recent News

Fulcrum Therapeutics, Inc. (FULC)

Factor Profile

Date	Insider	Type	Shares	Value
2026-07-17	TANG KEVIN	P	50,945	$179,326.4
2026-07-16	TANG KEVIN	P	116,671	$415,348.76
2026-07-15	TANG KEVIN	P	107,377	$382,262.12
2026-07-14	TANG KEVIN	P	75,952	$271,908.16
2026-07-14	TANG KEVIN	P	53,651	$190,997.56